Search U.S. Product Recalls Database

Showing 12961–12980 of 14370 results

Sort:

Propranolol HCL ER Capsules (Aidapak) – label mixup (2013)

Labeling: Label Mixup: PROPRANOLOL HCL ER, Capsule, 60 mg may have potentially been mislabeled as the following drug: CINACALCET HCL, Tablet, 30 mg, NDC 55513007330, Pedigree: AD52778_82, EXP: 5/21/2014.

Class IIModerate

FDAJul 2, 2013AZ, CA, IN +2 more• Aidapak Services, LLC

Atorvastatin Calcium Tablets (Aidapak) – label mixup (2013)

Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 10 mg may have potentially been mislabeled as one of the following drugs: PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121201, Pedigree: AD30180_4, EXP: 5/8/2014; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD49399_4, EXP: 5/16/2014; ASPIRIN, CHEW Tablet, 81 mg, NDC 00536329736, Pedi

Class IIModerate

Stay Informed

Search Product Recalls

Propranolol HCL ER Capsules (Aidapak) – label mixup (2013)

Atorvastatin Calcium Tablets (Aidapak) – label mixup (2013)

Cinacalcet HCL (Aidapak) – Label Mixup (2013)

Magnesium Chloride (Aidapak) – Label Mixup (2013)

Benztropine Mesylate Injection (Fresenius Kabi) – Glass Delamination (2013)

Duet DHA Balanced Multivitamin (Stayma Consulting) – Subpotent Vitamin A (2013)

Duet DHA 430 Multivitamin (Stayma Consulting) – Subpotent Vitamin A (2013)

Duet DHA 400 Multivitamin (Stayma Consulting) – Subpotent Vitamin A (2013)

Fem-Vite Women's Anti-Oxidant Formula (Vinco) – Salmonella risk (2013)

Duet DHA 400 EC Multivitamin (Stayma Consulting) – Subpotent Vitamin A (2013)

Nata Komplete Multivitamin (Stayma Consulting) – Subpotent Vitamin A (2013)

Duet DHA 430 EC Multivitamin (Stayma Consulting) – Subpotent Vitamin A (2013)

NataChew Multivitamin (Stayma Consulting) – Subpotent Vitamin A (2013)

Clalis Capsules (Fabscout) – Unapproved Ingredient (2013)

Silver Sword Capsules (Fabscout) – Unapproved Ingredient (2013)

Sodium Chloride Injection (Hospira) – Particulate Matter (2013)

Latanoprost Ophthalmic Solution (Apotex) – Sterility Concern (2013)

Oxytocin Injection (Fresenius Kabi) – Subpotent Drug (2013)

Gastrografin (Bracco Diagnostics) – Foreign Substance Risk (2013)

Merrem IV Injection (AstraZeneca) – Precipitate Concern (2013)